Alembic Pharma gets EIR from USFDA for Karakhadi facility The US regulator has also indicated that a compliance verification would be performed during re-inspection of the said facility in the next review cycle, it added.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.